Clinical Trial Update: Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia

View source ↗

Summary

This clinical trial update reports on the safety, effectiveness, and patient acceptance of MabCampath (alemtuzumab) in chronic lymphocytic leukemia, noting that…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• MabCampath (alemtuzumab)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Chronic Lymphocytic Leukemia | Status: TERMINATED